Skip to content
mapperlab
← Dashboard
Stock

PRVA

Privia Health Group, Inc.
Health CareHealth Care ServicesLatest close $247 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
10
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Aug 16, 2021Aug 9, 2024May 15, 2025May 15, 2026
Now
7

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$32$24-27%
Renaissance Technologies$19$24+24%
Citadel Advisors$19$24+23%
AQR Capital Management$19$24+23%
Millennium Management$19$24+23%
D.E. Shaw$23$24+1%
Point72 Asset Management$23$24+1%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Two Sigma Investments→ $23+19%
Soros Fund Management→ $25+29%
Maverick Capital→ $28-14%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Privia Health Group, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
12
Filings · last 90d
25
Total on file
275
Recent SEC buffer
Most recent
May 22, 2026

30d / 90d windows measured from May 22, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 275 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Privia Health Group, Inc.

Annual figures sourced directly from Privia Health Group, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$2.12B
FY2025+22% YoY
Net income
$22.92M
FY2025+59% YoY
EPS (diluted)
$0.1800
FY2025+64% YoY
Free cash flow(?)
$163.4M
FY2025+50% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Privia Health Group, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
D.E. ShawQ4 2025open$23$24+1%
Point72 Asset ManagementQ4 2025open$23$24+1%
Bridgewater AssociatesQ4 2025open$24$21-12%
Citadel AdvisorsQ3 2024open$19$24+23%
Soros Fund ManagementQ3 2024Q2 2025$19$25+29%
Two Sigma InvestmentsQ3 2024Q2 2026$19$23+19%
AQR Capital ManagementQ3 2024open$19$24+23%
Millennium ManagementQ3 2024open$19$24+23%
Renaissance TechnologiesQ3 2024open$19$24+24%
Bridgewater AssociatesQ4 2021Q2 2025$32$24-25%
Maverick CapitalQ3 2021Q1 2023$32$28-14%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.